SUBSCRIBE
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
TECHNOLOGY
- Cybersecurity
MARKETS
HOW-TO
VIDEO
- Audio
Courses
- Personal Finance Essentials
- Fundamentals of Investing
Mavens on TheStreet

Terms Of Use
Privacy Policy
Advertise
Reprints
Customer Service
Data
Topic Archive
Subscriptions
Privacy Settings

JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
TECHNOLOGY
MARKETS
HOW-TO
VIDEO
COURSES

Log In

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.

Forgot your password?

Don't have an account? Sign Up Here

Join Us

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.

I agree to TheMaven's Terms and Policy

Already have an account? Login here

Alerts
|
Newsletters

JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
TECHNOLOGY
MARKETS
HOW-TO
VIDEO
COURSES

Pharmaceuticals

AstraZeneca Heart Drug Trial No Longer Subject of a Federal Probe

Amarin Shares Crushed After Judge Rules Heart Drug Patents Invalid: Report

By Tom Bemis

Coronavirus vaccine Lead

How Do New Drugs Actually Get Approved?

Coronavirus Lockdown Lead

No Miracle Treatment for Coronavirus Yet, Says Novartis CEO

Vasant Narasimhan

Novartis CEO Cautions on Efficacy of Trump-Touted Covid-19 Treatment

By M. Corey Goldman

Setback for Bristol-Myers on Lung Cancer Treatment Drugs

China Suspends Use of BeiGene Cancer Drug Abraxane

By Dan Weil

What Does CVS's Aetna Acquisition Mean for Amazon?

CVS's Aetna Reduces Hospital Costs for Coronavirus Patients

By Dan Weil

Novavax CEO: Avian Flu Results Very Positive for Vaccine Maker

Novavax Surges as Late-Stage Flu Treatment Achieves Endpoints

By Rob Lenihan

Coronavirus: From Vaccines To Getting Back To Work, China Turns To Science For Answers To The Big Questions

Moderna: Virus Vaccine May Be Available to Aid Workers by Fall, Wider Provision in 12-18 Months

By Dan Weil

Takeda Pharmaceutical CEO Talks Big Pharma Trends

Takeda Eyes Plasma Therapy for Covid-19 Patients

By Adam Smith

Coronavirus Lockdown Lead

A Legal Look at the Drugs Being Used to Potentially Treat Coronavirus

Why Teva Pharmaceuticals Shares Are Losing Steam

Teva Donates 6 Million Tablets of Malaria Drug to Fight Coronavirus in U.S.

By Dan Weil

Wuhan Cherry Blossom Live Stream Launched Amid Coronavirus Lockdown

Coronavirus Scammers Emerge to Prey on Public’s Fears

By Tom Bemis

Abbott Laboratories Lead

Abbott Jumps Into The Coronavirus Fight Club

Coronavirus Stock Market Lead

Trump Says FDA Clears 2 Antivirals to Battle Coronavirus Symptoms

By Tony Owusu

Jim Cramer: We Remain Excited About Abbott Laboratories for Action Alerts Plus

Abbott Labs Gets FDA Emergency Nod for Coronavirus Tests

By M. Corey Goldman

Trump Contradicts Advisers On Proposed Trade Limits To China While Pushing Aircraft Deals

Trump to Invoke the Defense Production Act to Combat Coronavirus Pandemic

By Rob Lenihan

Hong Kong And Shanghai-listed Fosun Pharma Says It Has Sought Approval From Beijing For Its Coronavirus Test Kits

Hologic, Others Ramp Up Covid-19 Test-Kit Production

Hologic, Marks & Spencer and Sensata Set to Enjoy Strong Growth

Hologic Ramps Up Coronavirus Test Kit Production

By M. Corey Goldman

Jim Cramer: Stay Long Thermo Fisher, Sell FEI

Thermo Fisher Garners FDA Emergency Nod for Coronavirus Test

By Dan Weil

Vaccinations Will Give Your Child Autism

Moderna Prepping Covid-19 Vaccine Test Trial

Inovio Stock Rises on Positive Results From Ebola Vaccine Tests

Moderna Coronavirus Vaccine Trial Set to Begin

By M. Corey Goldman

Roche Shares Gain; CEO 'Fully Dedicated' to Key U.S. Market

Roche To Start Mass-Producing Coronavirus Tests

Biotech Movers: Inovio, Neurocrine, Alnylam

Inovio Gets Downgrades Despite Grant for Coronavirus Test

By Rob Lenihan

Coronavirus Lead

GenMark Diagnostics Submits Test for Coronavirus to FDA

By Dan Weil

Terms Of Use
Privacy Policy
Advertise
Reprints
Customer Service
Data
Topic Archive
Subscriptions

© 2020 TheStreet, Inc. All rights reserved. Action Alerts PLUS is a registered trademark of TheStreet, Inc.